By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751



Company News
Sarepta (SRPT) Announces Second Quarter 2016 Financial Results And Recent Corporate Developments 7/20/2016 8:46:08 AM
Sarepta (SRPT)'s Study Period Extension May Help Gain DMD Drug Approval in the Long Run 6/24/2016 6:50:00 AM
Sarepta (SRPT) Announces Common Stock Offering 6/9/2016 8:29:07 AM
Sarepta (SRPT) Surges Yet Again, as the FDA Requests More Data About Duchenne’s Drug 6/7/2016 5:55:29 AM
All Eyes Turn to Sarepta (SRPT) as BioMarin (BMRN) Shutters Its Kyndrisa Duchenne Program 6/1/2016 6:25:05 AM
Approving Sarepta (SRPT)'s DMD Drug Could Force FDA To Get Creative 5/26/2016 7:44:39 AM
Sarepta (SRPT) Rockets After the FDA Delays Ruling on DMD Drug 5/25/2016 5:52:53 AM
Sarepta (SRPT) Who? This DMD Drugmaker Might be a Better Buy for Investors 5/20/2016 6:40:26 AM
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/11/2016 11:10:15 AM
Betting Intensifies Over Sarepta (SRPT)’s DMD Drug 5/6/2016 7:39:20 AM